Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-31

Clinical Trial Update: Safety Study of Bone Marrow Derived Stem Cells on Patients With Cutaneous Photoaging [Phase 1, Phase 2]

View source ↗

Summary

A safety study evaluating bone marrow-derived stem cells for treating photoaged skin has been conducted in Phase 1/2, with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bone marrow-derived stem cells

Snippet

Sponsor: Stemedica Cell Technologies, Inc. | Conditions: Chronic Effect of Ultraviolet Radiation on Photoaged Skin, Dermatologic Disorders | Phase 1, Phase 2 | Status: UNKNOWN